Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reinaldo Acevedo

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
BMC Immunology|March 6, 2013
Pilot scale production of the vaccine adjuvant Proteoliposome derived Cochleates (AFCo1) from Neisseria meningitidis serogroup BCaridad Zayas, Domingo González, Reinaldo Acevedo, et al.
Immunology and Cell Biology|November 20, 2004
Novel adjuvant based on a proteoliposome-derived cochleate structure containing native lipopolysaccharide as a pathogen-associated molecular patternOliver Pérez, Gustavo Bracho, Miriam Lastre, et al.
Methods (San Diego, Calif.)|June 24, 2009
Intranasal administration of proteoliposome-derived cochleates from Vibrio cholerae O1 induce mucosal and systemic immune responses in miceReinaldo Acevedo, Adriana Callicó, Judith del Campo, et al.
Vaccine|July 11, 2006
Proteliposome-derived Cochleate as an immunomodulator for nasal vaccineOliver Pérez, Gustavo Bracho, Miriam Lastre, et al.
Pharmacological Research|May 13, 2017
Outer membrane vesicles extracted from Neisseria meningitidis serogroup X for prevention of meningococcal disease in AfricaReinaldo Acevedo, Caridad Zayas, Gunnstein Norheim, et al.
Expert Review of Vaccines|December 12, 2018
The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: Epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populationsReinaldo Acevedo, Xilian Bai, Ray Borrow, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
BMC Immunology|March 6, 2013
Pilot scale production of the vaccine adjuvant Proteoliposome derived Cochleates (AFCo1) from Neisseria meningitidis serogroup BCaridad Zayas, Domingo González, Reinaldo Acevedo, et al.
Immunology and Cell Biology|November 20, 2004
Novel adjuvant based on a proteoliposome-derived cochleate structure containing native lipopolysaccharide as a pathogen-associated molecular patternOliver Pérez, Gustavo Bracho, Miriam Lastre, et al.
Methods (San Diego, Calif.)|June 24, 2009
Intranasal administration of proteoliposome-derived cochleates from Vibrio cholerae O1 induce mucosal and systemic immune responses in miceReinaldo Acevedo, Adriana Callicó, Judith del Campo, et al.
Vaccine|July 11, 2006
Proteliposome-derived Cochleate as an immunomodulator for nasal vaccineOliver Pérez, Gustavo Bracho, Miriam Lastre, et al.
Pharmacological Research|May 13, 2017
Outer membrane vesicles extracted from Neisseria meningitidis serogroup X for prevention of meningococcal disease in AfricaReinaldo Acevedo, Caridad Zayas, Gunnstein Norheim, et al.
Expert Review of Vaccines|December 12, 2018
The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: Epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populationsReinaldo Acevedo, Xilian Bai, Ray Borrow, et al.
Pageof 3